Recombinant SS18-SSX (Marker of Synovial Sarcoma) Antibody, Clone: [SS18.SSX/12628R], Rabbit, Monoclonal

Artikelnummer: NBT-RBM1-12628-P1ABX
Artikelname: Recombinant SS18-SSX (Marker of Synovial Sarcoma) Antibody, Clone: [SS18.SSX/12628R], Rabbit, Monoclonal
Artikelnummer: NBT-RBM1-12628-P1ABX
Hersteller Artikelnummer: RBM1-12628-P1ABX
Alternativnummer: NBT-RBM1-12628-P1ABX-100
Hersteller: NeoBiotechnologies
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IHC, WB
Spezies Reaktivität: Human
Immunogen: Recombinant fragment corresponding to the fusion site of human SS18-SSX protein (exact sequence is proprietary)
Alternative Synonym: SS18, SSXT, SYT
S18 is a protein that has been shown to be a part of the SWI/SNF complex. The SS18-SSX fusion proteins are a result of in-frame fusions that fuse the SS18 gene on chromosome 18 with X chromosome genes SSX1, SSX2, and to a lesser extent SSX4. Human synovial sarcoma (SS) accounts for 8-10% of all soft tissue malignancies and 95% of these malignancies express the recurrent translocation of the SS18 gene on chromosome 18. The N-terminal SNH domain (SYT N-terminal homology domain) of the SS18 protein interacts with SWI/SNF chromatin remodeling complexes via the N terminal region of BRM and BRG1 subunits. Studies of the SS18-SSX fusion in SS suggest that endogenous SS18 competes with the mutant SS18-SSX fusion for occupancy in the SWI/SNF complexes resulting in the displacement of SNF5 (BAF47) subunit. Displacement of the SNF5 subunit results in altered function of the SWI/SNF complex that leads to deregulated expression of genes such as Sox2 in SS.
Klonalität: Monoclonal
Klon-Bezeichnung: [SS18.SSX/12628R]
Molekulargewicht: 65/75kDa
NCBI: 6760
UniProt: Q15532
Formulierung: 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.